Evaluación de la eficacia y la seguridad de un protocolo de manejo de pacientes con diabetes descompensada por glucocorticoides durante la hospitalización

Perez, 2014, Glucocorticoid-induced hyperglycemia, J Diabetes., 6, 9, 10.1111/1753-0407.12090 Bonaventura, 2018, Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review, Diabetes Res Clin Pract., 139, 203, 10.1016/j.diabres.2018.03.006 Hwang, 2014, Steroid-induced diabetes: A clinical and molecular approach to understanding and treatment, Diabetes Metab Res Rev., 30, 96, 10.1002/dmrr.2486 Liu, 2014, Hyperglycemia induced by glucocorticoids in nondiabetic patients: A meta-analysis, Ann Nutr Metab., 65, 324, 10.1159/000365892 Kim, 2011, Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease, J Korean Med Sci., 26, 264, 10.3346/jkms.2011.26.2.264 Uzu, 2007, Glucocorticoid-induced diabetes mellitus: Prevalence and risk factors in primary renal diseases, Nephron-Clin Pract., 105, 15 Iwamoto, 2004, Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases, Pharmacotherapy., 24, 508, 10.1592/phco.24.5.508.33355 Umpierez, 2002, Hyperglucemia: An independent marker of in-hospital mortality in patients with undiagnosed diabetes, J Clin Endocrinol Metab., 87, 978, 10.1210/jcem.87.3.8341 Baker, 2006, Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease, Thorax., 61, 284, 10.1136/thx.2005.051029 American Diabetes Association. Diabetes Care in the hospital: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S144-S151. doi:10.2337/dc18-S014. Baldwin, 2013, Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes, Curr Diab Rep., 13, 114, 10.1007/s11892-012-0339-7 Umpierrez, 2012, Management of hyperglycemia in hospitalized patients in non-critical care setting: An endocrine society clinical practice guideline, J Clin Endocrinol Metab., 97, 16, 10.1210/jc.2011-2098 Sáenz-Abad, 2015, Evaluación de la eficacia de un protocolo destinado a mejorar el control glucémico de los pacientes con hiperglucemia ingresados en servicios hospitalarios de medicina interna, An Sist Sanit Navar., 38, 397, 10.4321/S1137-66272015000300004 Lakhani, 2017, Comparison of two protocols in the management of glucocorticoid-induced hyperglycemia among hospitalized patients, Indian J Endocrinol Metab., 21, 836, 10.4103/ijem.IJEM_226_17 Gosmanov, 2013, Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy, Endocr Pract., 19, 231, 10.4158/EP12256.OR Ruiz de Adana, 2015, Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respi, Diabetes Res Clin Pract., 110, 158, 10.1016/j.diabres.2015.09.015 Grommesh, 2016, Hospital insulin protocol AIMS for glucose control in glucocorticoid-induced hyperglycemia, Endocr Pract., 22, 180, 10.4158/EP15818.OR Dhital, 2012, A retrospective study comparing neutral protamine hagedorn insulin with glargine as basal therapy in prednisone-associated diabetes mellitus in hospitalized patients, Endocr Pract., 18, 712, 10.4158/EP11371.OR Radhakutty, 2017, Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study, Diabetes Obes Metab., 19, 571, 10.1111/dom.12859 Rys, 2015, Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus, Acta Diabetol., 52, 649, 10.1007/s00592-014-0698-4 Bazzano, 2008, Safety and efficacy of glargine compared with NPH insulin for the treatment of type 2 diabetes: A meta-analysis of randomized controlled trials, Diabet Med., 25, 924, 10.1111/j.1464-5491.2008.02517.x Brady, 2014, Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy, Diabetes Technol Ther., 16, 874, 10.1089/dia.2014.0115